Somatic status of pregnant women with SARS-CoV-2-associated pneumonias
https://doi.org/10.52888/0514-2515-2025-364-1-29-34
Abstract
Aim. To evaluate somatic status of pregnant women with SARS-CoV-2-associated pneumonia and its influence on the severity of the course of viral pneumonia
Material and methods. In this study, 70 pregnant women with SARS-CoV-2-associated pneumonia underwent clinical and laboratory examinations, PCR verification of SARS-CoV-2, chest x-ray in two projections, or computed tomography.
Results and discussion. I In the group of pregnant women with SARS-CoV-2-associated pneumonia, urinary tract pathology was detected in 50 patients (71.4%). This is five times higher than the frequency observed in the control group, where 5 pregnant women were diagnosed with urinary tract disease (14.3%; p < 0.001). Furthermore, iron deficiency anemia of varying degrees was observed in 52 pregnant women (74.3%), which was significantly higher than in controls, where it occurred in only 6 patients (17.1%; p<0.001). Cardiovascular diseases were observed in 8 pregnant women (11.4%) of the main group, while respiratory pathologies and allergies were rarely observed - only in 2 patients (2.9%).
Conclusion. Urinary system pathology and iron deficiency anemia were common comorbid conditions in pregnant women with SARS-CoV-2-associated pneumonia.
About the Authors
M. F. Davlyatova
SEI Avicenna Tajik State Medical University
Tajikistan
Tajikistan
Davlatova Mahina Farrukhovna - Candidate of medical sciences, associate professor
Tel: +992919053468
D. G. Karimova
SEI Avicenna Tajik State Medical University
Tajikistan
Tajikistan
M. A. Abduvalieva
SEI Avicenna Tajik State Medical University
Tajikistan
Tajikistan
References
1. Adamyan L.V. Beremennost i COVID-19: aktualnye voprosy (obzor literatury) [Pregnancy and COVID-19: current issues (literature review)]. Problemy reproduktsii – Reproduction Problems, 2021, No. 3, pp. 70-77.
2. Kalimatova D.M. Osobennosti techeniya beremennosti i rodov pri infektsii COVID-19 [Characteristics of the course of pregnancy and childbirth in COVID-19 infection]. Prakticheskaya meditsina – Practical Medicine, 2020, Vol. 18, No. 2, pp. 6-11.
3. Kalimatova D.M. Sovremennye predstavleniya o roli markerov disfunktsii endoteliya v razvitii patologii beremennosti pri ostrykh respiratornykh zabolevaniyakh [Current views on the role of markers of endothelial dysfunction in the development of pregnancy pathology in acute respiratory diseases]. Prakticheskaya meditsina – Practical Medicine, 2015, Vol. 86, No. 1, pp. 21-25.
4. Priputnevich T.V. Novyy koronavirus SARSCOV-2 i beremennost: obzor literatury [Novel SARSCOV-2 coronavirus and pregnancy: a review of the literature]. Akusherstvo i ginekologiya - Obstetrics and Gynecology, 2020, No. 5, pp. 6-12.
5. Sandakova E.A. Klinicheskie osobennosti techeniya virusnykh infektsiy dykhatelnykh putey u zhenshchin vo vremya beremennosti [Clinical features of the course of viral respiratory tract infections in women during pregnancy]. Permskiy meditsinskiy zhurnal – Perm Medical Journal, 2012, Vol. 29, No. 6, pp. 30-37.
6. Sinchikhin S.P. Novaya koronavirusnaya infektsiya i drugie respiratornye virusnye zabolevaniya u beremennykh: klinicheskaya lektsiya [New coronavirus infection and other respiratory viral diseases in pregnant women: a clinical lecture]. Ginekologiya – Gynecology, 2020, Vol. 22, No. 2, pp. 6-16
7. Swartz D., Graham A. Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARSCoV-2) Infecting Pregnant Women: Lessons From SARS, MERS, and Other Human Coronavirus Infections. Viruses, 2020, pp. 1–16.
8. Schwartz D.A., Graham A.L. Potential maternal and infant outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections. Viruses, 2020, Vol. 12, No. 194.
Review
For citations:
Davlyatova M.F., Karimova D.G., Abduvalieva M.A. Somatic status of pregnant women with SARS-CoV-2-associated pneumonias. Health care of Tajikistan. 2025;(1):29-34. (In Russ.) https://doi.org/10.52888/0514-2515-2025-364-1-29-34
Views:
289
Email this article 